Home » FDA Advisory Panel Endorses Approval of Solesta
FDA Advisory Panel Endorses Approval of Solesta
An FDA Advisory Panel voted 5–0, with one abstention, that the benefits of Solesta outweigh its risks.
iStockAnalyst
iStockAnalyst
Upcoming Events
-
07May
-
14May
-
30May